PROSTACYCLIN THERAPY OF THROMBOTIC THROMBOCYTOPENIC PURPURA
- 25 October 1980
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 316 (8200), 915
- https://doi.org/10.1016/s0140-6736(80)92071-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Effects of intravenous infusion of prostacyclin (PGI2) in manProstaglandins, 1980
- Human β-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cellsNature, 1979
- PROSTACYCLIN DEFICIENCY IN THROMBOTIC THROMBOCYTOPENIC PURPURAThe Lancet, 1979
- A double blind placebo controlled crossover study of prostacyclin in manLife Sciences, 1979
- INCREASED DOPAMINE CONCENTRATION IN LIMBIC AREAS OF BRAIN FROM PATIENTS DYING WITH SCHIZOPHRENIABrain, 1979
- Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendotheliumBlood, 1979
- HqMOLYTIC-URqMIC SYNDROME: DEFICIENCY OF PLASMA FACTOR(S) REGULATING PROSTACYCLIN ACTIVITY?The Lancet, 1978
- Anti-platelet action of intravenous infusion of prostacyclin in manThrombosis Research, 1978
- Circulatory and anti-platelet effects of intravenous prostacyclin in healthy menPharmacological Research Communications, 1978
- The Nature of the Vascular Lesion in Thrombotic Thrombocytopenic Purpura.Annals of Internal Medicine, 1968